Has Mimi Kim received payments from drug or device companies?

Yes. Drug and device makers reported $12,147 in general payments to Mimi Kim across 26 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mimi Kim did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mimi Kim come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mimi Kim

Developmental - Behavioral Pediatrics · Los Angeles, CANPI 1629296181

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,500 of the $12,147 with a category attached, or 78.2%. 7 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 52.4% of the total. 2025 is the largest year on record at $5,337, 5.0 times the $1,074 reported in 2019. Among developmental - behavioral pediatrics clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,147in general payments, 2019–2025

Across 26 payments — averaging $467.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neurocrine Biosciences, Inc.$6K
EMD Serono Research & Development Institute, Inc.$5K
Pfizer$1K
Eton Pharmaceuticals, Inc.$83
Boston Scientific$54
Abbott$54
plus $18 from 1 others

$649,013in research payments, 2019–2025

Across 296 payments — averaging $2192.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Neurocrine Biosciences, Inc.$647K
EMD Serono Research & Development Institute, Inc.$3K

What the payments were for

Consulting fees$9,50078%
Travel & lodging$1,65314%
Food & beverage$9958%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neurocrine Biosciences, Inc.	19	$6,365
EMD Serono Research & Development Institute, Inc.	1	$4,500
Pfizer	1	$1,074
Eton Pharmaceuticals, Inc.	1	$83
Boston Scientific	1	$54
Abbott	2	$54
Novo Nordisk	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CRENESSITY$241

How this compares

$12,147 in reported general payments places this provider in the 95th percentile of 52 developmental - behavioral pediatrics providers in California.

See all developmental - behavioral pediatrics providers in California →

Other developmental - behavioral pediatrics in Los Angeles

Anshu BatraLos Angeles$2K
Audrey GriesbachLos Angeles$895
Gregory KennedyLos Angeles$583
Larry YinLos Angeles$577
Jeffrey YangLos Angeles$279
David SchonfeldLos Angeles$265
Won KimLos Angeles$148
Tamar ChorbadjianLos Angeles$109
Sai IyerLos Angeles$25
Jennifer HanLos Angeles$23

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →